Skip to main content

Masimo Corporation (MASI)

NASDAQ: MASI · IEX Real-Time Price · USD
283.00
-2.47 (-0.87%)
After-hours:Oct 25, 2021 5:54 PM EDT
285.47
2.12 (0.75%)
At close: Oct 25, 4:00 PM
Market Cap15.68B
Revenue (ttm)1.18B
Net Income (ttm)223.69M
Shares Out55.03M
EPS (ttm)3.86
PE Ratio73.94
Forward PE68.03
Dividendn/a
Ex-Dividend Daten/a
Volume348,496
Open283.35
Previous Close283.35
Day's Range279.37 - 285.66
52-Week Range205.10 - 288.27
Beta0.78
AnalystsBuy
Price Target298.80 (+4.7%)
Est. Earnings DateOct 26, 2021

About MASI

Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. It also provides Masimo rainbow SET platform that includes rainbow SET Pulse CO-Oximetry products that noninvasively monitor hemoglobin species, including oxygen saturation, pulse rate, perfusion ind...

IndustryHealth Care Equipment & Supplies
IPO DateAug 8, 2007
CEOJoseph Kiani
Employees2,000
Stock ExchangeNASDAQ
Ticker SymbolMASI
Full Company Profile

Financial Performance

In 2020, Masimo's revenue was $1.14 billion, an increase of 21.96% compared to the previous year's $937.84 million. Earnings were $240.30 million, an increase of 22.47%.

Financial Statements

Analyst Forecast

According to 9 analysts, the average rating for Masimo stock is "Buy." The 12-month stock price forecast is 298.80, which is an increase of 4.67% from the latest price.

Price Target
$298.80
(4.67% upside)
Analyst Consensus: Buy

News

Masimo (MASI) Earnings Expected to Grow: Should You Buy?

Masimo (MASI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

6 days ago - Zacks Investment Research

New Study Recommends the Use of Masimo PVi® to Guide Fluid Administration During Major Oncosurgery with Lung Ultrason...

IRVINE, Calif.--(BUSINESS WIRE)--An abstract presented at ANESTHESIOLOGY 2021 recommended use of noninvasive, continuous Masimo PVi® to guide fluid administration during oncosurgery.

1 week ago - Business Wire

Masimo to Report Third Quarter 2021 Financial Results After Market Close on Tuesday, October 26

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) will release third quarter 2021 financial results for the period ended October 2, 2021, after the market closes on Tuesday, October 26, 2021. The c...

1 week ago - Business Wire

Masimo's (MASI) EMMA Capnography on Neonates Favored by New Study

Masimo's (MASI) EMMA is likely to aid in maintaining an optimal range of PaCO2 in preterm infants undergoing mechanical ventilation in the neonatal intensive care unit.

3 weeks ago - Zacks Investment Research

New Study Evaluates the Feasibility of Using Masimo EMMA® Capnography on Mechanically Ventilated Neonates

TOKYO--(BUSINESS WIRE)--A new study found that the Masimo EMMA® Portable Capnograph "may be considered an effective monitoring device" for mechanically ventilated neonates.

4 weeks ago - Business Wire

Here's Why You Should Retain Masimo (MASI) Stock For Now

Investors continue to be optimistic about Masimo (MASI) owing to its slew of product launches and regulatory approvals.

1 month ago - Zacks Investment Research

Masimo CEO Joe Kiani Appointed to President's Council of Advisors on Science and Technology

IRVINE, Calif.--(BUSINESS WIRE)--Masimo Founder and CEO Joe Kiani has been appointed to President Biden's Council of Advisors on Science and Technology.

1 month ago - Business Wire

5 Good Companies With High Profitability

According to the “Good Companies Screen,” one of several Premium screens under the All-in-One Screener, five stocks with high financial strength and profitability are Edwards Lifesciences Corp. ( EW , F...

Other symbols:EWGGGLULUUSNA
1 month ago - GuruFocus

Cybersecurity Gains Prominence in MedTech: 3 Stocks to Focus on

Technology-based healthcare stocks like Henry Schein (HSIC), Veeva Systems (VEEV) and BD (BDX) are expected to continue their rally over the next few months.

Other symbols:BDXHSICVEEV
1 month ago - Zacks Investment Research

Masimo (MASI) Launches SuperSensor, Boosts Product Profile

Masimo's (MASI) launch of SuperSensor can help clinicians to continuously monitor patients through one comprehensive, convenient, noninvasive fingertip solution.

1 month ago - Zacks Investment Research

Masimo Launches Single-patient-use rainbow® SuperSensor™

NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo announces the CE marking & European launch of the single-patient-use rainbow® SuperSensor™, with 12 noninvasive parameters on a single sensor.

1 month ago - Business Wire

Masimo to Present in Morgan Stanley 19th Annual Global Healthcare Conference

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that its management is scheduled to participate in the Morgan Stanley 19th Annual Global Healthcare Conference on Thursday, Septemb...

1 month ago - Business Wire

Masimo's (MASI) ORi Favored by New Study For ICU Patients' ETI

Masimo's (MASI) ORi is expected to provide early warnings of impending hypoxemia during the ETI procedure, thus aiding in averting any adverse incident.

1 month ago - Zacks Investment Research

Masimo (MASI) Ties Up to Educate on Prescription Opioid Overuse

Masimo (MASI) partners with Penington Institute to increase awareness on overdose from prescription opioids.

1 month ago - Zacks Investment Research

New Study Investigates the Ability of Masimo ORi™ to Provide Early Warning of Hypoxemia During Endotracheal Intubatio...

NEUCHATEL, Switzerland--(BUSINESS WIRE)--A new study found that use of Masimo ORi™ on ICU patients may facilitate "preventive action" against hypoxemia during endotracheal intubation.

1 month ago - Business Wire

Masimo Stock Will Likely Continue To Make Fresh Highs

The stock price of Masimo Corporation, a medical devices company best known for its remote patient monitoring systems, reached its all-time high of $287 just last week before a recent decline resulted i...

1 month ago - Forbes

Masimo (MASI) Strengthens Global Footprint With New Launch

Masimo's (MASI) western Europe launch of SafetyNet Alert not only expands its global presence but also aids in protecting patients taking opioids at home.

1 month ago - Zacks Investment Research

Masimo Partners with Penington Institute to Raise Awareness of Harm from Prescription Opioid Overdose

LONDON--(BUSINESS WIRE)--Masimo is marking International Overdose Awareness Day by partnering with the Penington Institute to raise awareness of the risks of opioid overdose.

1 month ago - Business Wire

Masimo SafetyNet Alert™ Launches in Western Europe

NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo SafetyNet Alert™, an oxygen saturation monitoring and alert system designed for use at home, has been launched in Western Europe.

1 month ago - Business Wire

Masimo (MASI) Up 6% Since Last Earnings Report: Can It Continue?

Masimo (MASI) reported earnings 30 days ago. What's next for the stock?

1 month ago - Zacks Investment Research

Society for the Advancement of Patient Blood Management (SABM) Publication Recommends Continuous Hemoglobin Monitoring

IRVINE, Calif.--(BUSINESS WIRE)--Society for the Advancement of Patient Blood Management (SABM) Publication Recommends Continuous Hemoglobin Monitoring

1 month ago - Business Wire

Here's Why You Should Retain Masimo (MASI) Stock For Now

Investors continue to be optimistic about Masimo (MASI) owing to its slew of product launches and regulatory approvals.

2 months ago - Zacks Investment Research

Masimo's (MASI) Noninvasive Continuous PVi Favored by New Study

Masimo (MASI) reports study findings that will aid clinicians in getting meaningful information with respect to monitoring the volume status in critically ill patients with spontaneous breathing.

2 months ago - Zacks Investment Research

New Study Evaluates the Use of Masimo PVi® to Monitor Volume Status in Spontaneously Breathing Hemodialysis Patients

NEUCHATEL, Switzerland--(BUSINESS WIRE)--A study found a "strong correlation" between change in Masimo PVi® & volume of fluid removed during hemodialysis in spontaneously breathing patients.

2 months ago - Business Wire

Masimo (MASI) Bridge Hailed as Opioid Substitute in New Study

Masimo's (MASI) Bridge device is likely to allow more patients to be benefited by auriculotherapy, thereby reducing the possibility of opioid overuse.

2 months ago - Zacks Investment Research